Cormorant Asset Management, LP Homology Medicines, Inc. Transaction History

Cormorant Asset Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$8.92 - $13.29 $4.2 Million - $6.26 Million	-470,897 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$9.94 - $16.59 $786,283 - $1.31 Million	-79,103 Reduced 14.38%	470,897 $5.04 Million
Q2 2020 Aug 14, 2020	SELL	$12.07 - $19.34 $603,500 - $967,000	-50,000 Reduced 8.33%	550,000 $8.36 Million
Q1 2020 May 15, 2020	BUY	$12.5 - $22.04 $7.5 Million - $13.2 Million	600,000 New	600,000 $9.32 Million
Q4 2019 Feb 14, 2020	SELL	$11.42 - $22.19 $2.8 Million - $5.44 Million	-245,100 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$14.74 - $22.28 $809,226 - $1.22 Million	-54,900 Reduced 18.3%	245,100 $4.44 Million
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $5.51 Million - $9.1 Million	300,000 New	300,000 $5.87 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.